Navigation path

Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use

Renin-angiotensin system (RAS)-acting agents

Product name: Renin-angiotensin system (RAS)-acting agents
Active substance: benazepril, captopril, cilazapril, delapril, enalapril, fosinopril, imidapril, lisinopril, moexipril, perindopril, quinapril, ramipril, spirapril, trandolapril, zofenopril, candesartan, eprosartan, losartan, olmesartan, valsartan
Indication: The renin-angiotensin system (RAS) is a hormone system that regulates blood pressure and fluid balance. RAS-acting agents act by blocking different stages of the renin-angiotensin system, lowering blood pressure and their use in the treatment of hypertension and its complications (including acute myocardial infarction, congestive heart failure and chronic kidney disease) is recommended in many current clinical guidelines.
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/09/2014 Referral EMEA/H/A-31/1370 (2014)6371 of 04/09/2014